𝔖 Bobbio Scriptorium
✦   LIBER   ✦

457 “DE NOVO” AMYLOIDOSIS IN RECIPIENTS OF DOMINO LIVER TRANSPLANTATION: CLINICAL AND HISTOLOGICAL DATA

✍ Scribed by C. Baliellas; L. Lladó; C. Casasnovas; J. Castellote; J. Fabregat; I. Ferrer; R. Rota; J. Torras; E. Ramos; X. Xiol; A. Rafecas


Book ID
117378542
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
66 KB
Volume
52
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clinical symptomatic de novo systemic tr
✍ Ana Paula Barreiros; Christian Geber; Frank Birklein; Peter R. Galle; Gerd Otto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Four years ago, Stangou et al. 1 reported a patient who developed clinical symptoms of amyloidosis 8 years after domino liver transplantation (DLT). In order to alleviate the graft shortage, livers from patients with familial amyloidotic polyneuropathy (FAP) are used as domino grafts for other pati

The clinical course of transplantation-a
✍ Douglas, D D ;Rakela, J ;Wright, T L ;Krom, R A ;Wiesner, R H 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 159 KB 👁 1 views

Transmission of hepatitis B infection from hepatitis B surface antigen (HBsAg)-negative antibody to hepatitis B core (anti-HBc)-positive liver donors has been previously described. The longterm outcome of these transplant-associated de novo hepatitis B patients has not been well described and may a